Search

Why don't we have phage therapy yet? We want to understand why. On the Podovirus podcast, we interview people we think could have the answers. 🎙️ Most recent episode: Joe and Jessica interviewed Dr. Saima Aslam, clinical lead at IPATH abo

Lawrence Berkeley National Lab is hiring a Postdoctoral Fellow to study microbial genomics and engineered living materials for critical mineral recovery.

Jessica was interviewed on the Development & Research podcast, a new video interview series by biotech investor/economist Ross Rheingans-Yoo about people doing things differently in clinical trials and drug development. They discussed oper

The 6th International Conference on Bacteriophage Research & Antimicrobial Resistance is taking place November 12–13, 2025, in Varanasi, India. Hosts: the Institute of Medical Sciences–Banaras Hindu University along with the Society for Ba

The Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) is coming up early next year on January 28-30, 2026 in Las Vegas.   The meeting will bring together the top scientists, innovators, and cross-sector leaders to

Naia Novy (University of Wisconsin-Madison) and colleagues published a new paper on multiobjective machine learning design of phage specificity, showing deep learning can successfully design T7 phages with precisely tuned infectivity, speci

Shelby Andersen (University of Colorado Anschutz Medical Campus) and colleagues published a new paper on systematic phage gene function interrogation, showing PhageMaP enables high-throughput screening of phage mutant libraries to decipher

Zhiying Zhang (Memorial Sloan Kettering Cancer Center) and colleagues published a new paper on a membrane-embedded Kiwa defense supercomplex mechanism, showing KwaA and KwaB form transmembrane complexes that detect phage attachment and bind

Hannah Kapoor (Oregon State University) and colleagues published a new paper on phage-mediated TLR2 signaling against intracellular Mycobacterium abscessus, showing certain mycobacteriophages stimulate TLR2 signaling and NLRP3 inflammasome

Amit Vikram (Intralytix) and colleagues published a new paper on phage cocktail biocontrol in wheat milling operations, showing significant E. coli O157:H7 reductions of 1.4-3.1 log CFU/g without affecting flour quality or baking properties

Feature on the Reference Center for Complex Osteoarticular Infections (CrioaC) at Croix-Rousse Hospital in Lyon, where Professor Tristan Ferry's team treats patients at a therapeutic impasse with phages, a treatment the service has pioneere

University of Waterloo School of Pharmacy researchers use a modified version of the M13 bacteriophage to deliver chosen therapeutic genes to specific human cells, with no unwanted virus or bacteria, as a cheaper and more efficient route to

In a Form 8-K dated August 19, 2025, BiomX reported that the FDA placed a clinical hold on its Phase 2b study of BX004 in cystic fibrosis while it reviews data on a third-party nebulizer used to deliver BX004. The FDA raised no concerns abo

"When I first treated, we had no idea how much to give, how often to give... we weren't aware of what the concentration of phage should be." IPATH's Dr. Saima Aslam shares how eight years of treating patients has taught her team to achieve

Lawrence Berkeley National Lab is hiring a Postdoctoral Fellow to study microbial genomics and engineered living materials for critical mineral recovery.

The 6th International Conference on Bacteriophage Research & Antimicrobial Resistance is taking place November 12–13, 2025, in Varanasi, India. Hosts: the Institute of Medical Sciences–Banaras Hindu University along with the Society for Ba

The Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) is coming up early next year on January 28-30, 2026 in Las Vegas.   The meeting will bring together the top scientists, innovators, and cross-sector leaders to

Saima Aslam and colleagues at University of California, San Diego have announced Phase I/II phage vs placebo trial for recurrent E. coli UTIs in female kidney transplant recipients.

Jérémy Cherbuin (Lausanne University Hospital) and colleagues published a new paper on in vivo podovirus resistance via tarS mutations, showing tarS disruption causes phage 66 resistance in MSSA endocarditis through impaired wall teichoic a

Jiayu Gu (Chinese Academy of Sciences) and colleagues published a new paper on crosstalk between inovirus core gene and accessory toxin-antitoxin system, showing RepG4 protein from Pf4 phage triggers degradation of PfpC antitoxin, coordinat